Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 65.25
-0.33 (-0.50%)
At close: Nov 14, 2025
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 30.09 billion as of November 14, 2025. Its market cap has increased by 66.62% in one year.
Market Cap
30.09B
Enterprise Value
29.23B
Revenue
607.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.25
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 30.09B, an increase of 83.04%. That is a compound annual growth rate of 16.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 30.09B | 74.58% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 282.16B |
| Shenzhen Mindray Bio-Medical Electronics | 251.19B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |